These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

130 related items for PubMed ID: 666447

  • 1. [Clinical value of a new method of therapeutic control of heparin].
    Pizzuto J, Garcia S, de la Paz Reyna M, Morales MR, Avilés A, Zavala B, Ponce L, Gaos C.
    Arch Inst Cardiol Mex; 1978; 48(2):373-86. PubMed ID: 666447
    [Abstract] [Full Text] [Related]

  • 2. Clotting, activated partial thromboplastin and coagulation times in monitoring heparin therapy.
    Kurec AS, Morris MW, Davey FR.
    Ann Clin Lab Sci; 1979; 9(6):494-500. PubMed ID: 518012
    [Abstract] [Full Text] [Related]

  • 3. Clinical evaluation of new global clotting assay for monitoring of LMWH treatment: pilot study.
    Makris PE, Pithara E.
    Int Angiol; 1998 Jun; 17(2):69-79. PubMed ID: 9754892
    [Abstract] [Full Text] [Related]

  • 4. [Monitoring of heparin therapy with activated recalcification time].
    Lutze G, Schlote A, Urbahn H.
    Z Gesamte Inn Med; 1981 Feb 15; 36(4):102-6. PubMed ID: 7222858
    [Abstract] [Full Text] [Related]

  • 5. [Laboratory controls of heparin therapy with thrombin time, partial thromboplastin time and activated recalcification time].
    Lutze G, Presser HJ, Urbahn H.
    Z Gesamte Inn Med; 1989 Apr 15; 44(8):235-40. PubMed ID: 2662657
    [Abstract] [Full Text] [Related]

  • 6. [The kaolin-activated recalcification test in the screening of coagulation disorders and in the control of anticoagulant therapy].
    Barberi G, Fiocca S.
    Quad Sclavo Diagn; 1977 Jun 15; 13(2):167-75. PubMed ID: 594303
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. On the value of the activated partial thrombo-plastin time (aptt) in monitoring heparin therapy.
    Teien AN, Abildgaard U.
    Thromb Haemost; 1976 Jun 30; 35(3):592-7. PubMed ID: 989966
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. [Comparative multicenter study of a rabbit high-sensitivity thromboplastin and a recombinant thromboplastin with synthetic phospholipids].
    Martínez-Brotóns F, Borrell M, Fontcuberta J, Batlle J, López F, Páramo JA, Ribera C, Rocha E, Vicente V, Zuazu I.
    Sangre (Barc); 1994 Aug 30; 39(4):245-51. PubMed ID: 7985052
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Heparin dosing and monitoring for cardiopulmonary bypass. A comparison of techniques with measurement of subclinical plasma coagulation.
    Gravlee GP, Haddon WS, Rothberger HK, Mills SA, Rogers AT, Bean VE, Buss DH, Prough DS, Cordell AR.
    J Thorac Cardiovasc Surg; 1990 Mar 30; 99(3):518-27. PubMed ID: 2308370
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. [Monitoring heparin therapy by thrombin time and activated partial thromboplastin time--a comparison].
    Lang M, Fey MF, Furlan M, Beck EA.
    Schweiz Med Wochenschr; 1986 Nov 29; 116(48):1681-4. PubMed ID: 3798064
    [Abstract] [Full Text] [Related]

  • 17. In vivo and in vitro evaluation of the heparin management test versus the activated coagulation time for monitoring anticoagulation level in aprotinin-treated patients during cardiac surgery.
    Kim YS, Murkin JM, Adams SJ.
    Heart Surg Forum; 2004 Nov 29; 7(6):E599-604. PubMed ID: 15769695
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.